ARTICLE | Clinical News
Viaskin Milk: Phase IIa started
December 7, 2015 8:00 AM UTC
DBV began the double-blind, placebo-controlled, U.S. Phase IIa SMILEE trial to evaluate 500 ug Viaskin Milk once daily for 9 months in about 20 children ages 4-17 who are on a milk-free diet. Subjects...